calendar
68 catalysts · 18 phase 2 initiation · 15 phase 2 completion · 8 phase 1 completion · 6 phase 1 initiation · 4 phase 1 2 initiation · 3 phase 3 completion
next 91 dayslessmore
MonWedFri
68 catalysts · 18 phase 2 initiation · 15 phase 2 completion · 8 phase 1 completion · 6 phase 1 initiation · 4 phase 1 2 initiation · 3 phase 3 completion
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Therapy area: Oncology. Indication: Ovarian Cancer
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Recurrent Glioblastoma Multiforme (GBM)
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Immunology. Indication: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Therapy area: Immunology. Indication: Autoimmune Disorders, Diffuse Cutaneous Systemic Sclerosis, Systemic Sclerosis (Scleroderma)
Therapy area: Immunology, Mouth and Dental Disorders. Indication: Inflammation, Periodontal Disease, Periodontitis
Therapy area: Oncology. Indication: Pancreatic Cancer
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Solid Tumor
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer
Therapy area: Immunology, Respiratory. Indication: Allergic Rhinitis, Inflammation, Transplant Rejection
Therapy area: Oncology. Indication: Nasopharyngeal Cancer